. We examined the localization of r-staufen protein following treatment with raised an antibody to r-staufen; Western blot analysis revealed that the r-staufen protein is present in hippoinhibitors of either the actin-or microtubule-based cytoskeleton (cytochalasin B or nocodozole, respectively). campal homogenates and is detected as a single band by this antibody ( Figure 1C ). Fluorescence immunohisFor this, we constructed an r-staufen-GFP (green fluorescent protein) fusion and used Sindbis virus to express tochemistry with the same r-staufen antibody revealed a punctate, somatodendritic distribution pattern for the the stau-GFP in hippocampal neurons. (In this and all subsequent experiments, neurons were analyzed approtein in hippocampal slices and cultured hippocampal neurons (Figures 2 and 4C ). In slices, r-staufen was proximately 12 hr post infection.) The localization of r-staufen-GFP was very similar to that observed for the observed throughout the dendrites of CA1 neurons in both stratum radiatum and stratum lacunosum molecuendogenous r-staufen protein ( Figure 3) ; the fusion protein was present in the soma and dendrites exhibiting a lare (Figure 2 ). In addition, the cell bodies of putative interneurons as well as the granular and hilar cells of particularly punctate distribution in the distal dendrites. This dendritic localization of r-staufen was disrupted by the dentate gyrus also appeared r-staufen positive. In cultured neurons, r-staufen-positive particles were evinocodozole, but not cytochalasin B; nocodazole treatment did not result in the retraction of dendrites (Figure dent 3). These data indicate that r-staufen is actively trans-4C Figure 4A ). The sensitivity of the dendritic EtBr 1). As such, stau-RBD could act as a dominant negative, preventing the association of full-length staufen with signal to RNase, but not DNase treatment, indicated that under the appropriate experimental conditions, EtBr RNA. We tested the ability of stau-RBD to inhibit fulllength staufen mRNA association. As also shown by can be a specific reporter of RNA localization within neuronal dendrites ( Figure 4A) r-staufen, the distribution of stau-RBD in cultured hippolevels. In addition, we estimate that the concentration of stau-RBD in infected neurons is at least 10ϫ-20ϫ campal neurons was limited to the soma and very proximal dendrites, as indicated by simultaneous immunogreater than the endogenous staufen in control GFPexpressing neurons (see Experimental Procedures). staining for MAP2 ( Figure 5A ). Note that the amount of stau-RBD protein present in infected neurons was Because stau-RBD was not efficiently transported to dendrites, we then asked whether its expression could statistically indistinguishable from that of the other GFP fusion proteins (e.g., stau-GFP and KH-GFP), indicating reduce the amount of dendritic RNA, by potentially competing with endogenous r-staufen. We compared the that its limited distribution is not due to lower protein When the actual localization was examined, however, RNA content; in these experiments, stau-RBD, but not the stau-tau fusion protein was present mainly in den-FMRP-KH, reduced the dendritic mRNA pool. Furtherdrites rather than axons.) When stau-tau-GFP was exmore, the observation that stau-RBD decreased denpressed in cultured neurons, the protein's distribution dritic mRNA levels but increased somatic mRNA levels was distinct from stau-GFP; namely, rather than being argues strongly against the idea that stau-RBD is affectclustered, stau-tau-GFP protein appeared diffusely dising mRNA stability or interfering with the antisense tributed in dendrites, perhaps consistent with tau's asprobe binding. Taken together with the results of EtBr sociation with microtubules (Goedert et al., 1991). We labeling of the RNA pool, these data suggest that staufen then examined the RNA distribution in stau-tau-GFP is important for the delivery of RNA to the dendrites. neurons and found its distribution was also changed to a diffuse pattern ( Figures 8A and 8C) . Taken complex and is necessary for its transport to the dendrites. When magnitude of inhibition produced by stau-RBD on the dendritic total RNA versus mRNA pool was com-
The ability of stau-RBD to reduce the total dendritic mRNA suggests that r-staufen associates with a potenpared, there was no significant difference. The similar inhibition of total RNA versus mRNA populations may tially broad spectrum of mRNAs or, alternatively, there is oligo (dT) and oligo (dA) (60 nucleotides) were 3Ј end labeled with digoxigenin-11-dUTP (Roche) according to manufacturer's instruction. Probes were purified using G-50 Micro Columns (Amersham GFP Constructs and Sindbis Viroid Preparation Pharmacia) followed by ethanol precipitation. The amount of purified pSinRep5-EGFP-staufen: the entire r-staufen ORF sequence was probes was determined by measuring their optical density. The final PCR amplified (upstream primer: 5Јcgcggatccgcgatggcaaatcccaaa concentration of probes in the hybridization solution was 250 ng/ gag3Ј; downstream promoter: 5Јcgcggatccgcgtcaggcagctggggct ml. Riboprobes for poly(A) RNA were also generated using a plasmid gaactagtc3Ј) and cloned into the BamH1 site of pEGFP-C1 plasmid containing 80 bp of A/T (Kleiman, 1993), and they gave the same (Clontech) to create an in-frame fusion with EGFP (pEGFP-staufen).
results as the oligo probes. The EGFP-staufen fragment was released with NheI and XbaI
In Situ Hybridization (blunted) and cloned into the XbaI/StuI sites of pSinRep5 (InFor hybridization, cells were fixed (4% paraformaldehyde; 4% suvitrogen). pSinRep5-EGFP-staufen-RBD: pEGFP-staufen plasmid crose) for 18 min at room temperature. The cells were washed with was digested with SpeI and XbaI, blunted, and self-ligated to create PBS/5 mM MgCl 2 for 3 ϫ 5Ј and 2 ϫ SSC for 2 ϫ 5Ј, followed by the pEGFP-staufen-RBD plasmid. The EGFP-staufen-RBD fragment incubation with equilibration solution (50% formamide, 0.6 M NaCl, was released with NheI and BclI (blunted), and cloned into the XbaI/ 10 mM Tri-HCl [pH 7.5], 1 mM EDTA, 50 g/ml heparin, 10 mM DTT) StuI sites of pSinRep5. pSinRep5-tau-EGFP-staufen: the tau coding for 5Ј and with prehybridization solution (same solution containing sequence was released from pETL (Mombaerts et al., 1996) with 10% PEG 8000 and 1 ϫ Denhardt's solution) for 2 hr at 50ЊC. The EcoRI and SacI, blunted, and cloned into the AgeI site of pEGFPcells were then incubated in hybridization solution (prehyb. sol. constaufen to create the ptau-EGFP-staufen. The tau-EGFP-staufen taining 0.5 mg/ml ssDNA, 0.5 mg/ml tRNA, and 250 ng/ml probe) at fragment was released by NheI and BclI (blunted) and cloned into 50ЊC overnight. After hybridization, the cells were incubated in 0.2 ϫ the XbaI/StuI sites of pSinRep5. pSinRep5-GFP-KH: the KH domains SSC for 10Ј followed by 2 ϫ 30Ј at 50ЊC, and then in PBT (1 ϫ PBS, were PCR amplified from the FMRP cDNA (Verkerk et al., 1993) 2 mg/ml BSA, 0.1% Triton X-100) at room temperature for 2 ϫ 15Ј. using the following primers: KH5Ј: cgggcccgagtaagcagctggagagtt Probes were detected by indirect immunostaining using an anticaagg3Ј; KH3Ј: cgggcccgttcaggtgataatccccaaaagaac3Ј. The PCR DIG monoclonal primary antibody and Cy3-conjugated secondary products were cloned in the ApaI site of pEGFP-C1 to create the antibody (Jackson). After hybridization, neurons expressing EGFP pEGFP-KH plasmid. The EGFP-KH fusion fragment was released or its fusion proteins were detected using anti-GFP antibody and from pEGFP-KH by NheI/SmaI digestion and cloned into the XBAI/ FITC-conjugated secondary antibody. STUI sites of pSinRep5. Sindbis viroids were produced according to the procedures provided by Invitrogen.
Confocal Data Acquisition
Confocal images were acquired in 1 m sections; image analysis RNA Binding Competition Assay and RBD Concentration Estimation was conducted on image z-stacks which contained the entire neuron of interest. EGFP and ethidium bromide were excited at 488 GST-staufen and GST-stau-RBD were expressed in bacteria and purified using Glutathione Sepharose beads. The stau-RBD portion nm. Emitted light collected between 510-550 nm corresponds to EGFP fluorescence, whereas emitted light collected above 600 nm of GST-stau-RBD fusion protein was released by thrombin digestion.
